Navigation Links
New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery
Date:5/9/2008

Novel Pain Medicine Studied in Patients Following Bunionectomy

TAMPA, Fla., May 9 /PRNewswire-USNewswire/ -- Many foot-surgery patients experience intense pain for several days following removal of a bunion, one of the most common foot surgeries. The investigational pain medication tapentadol provided significant relief for patients who had this surgery, compared to those treated with placebo. Treatment with tapentadol also resulted in patients reporting fewer gastrointestinal side effects compared to those treated with an older, prescription pain reliever, researchers announced today.

Results from a Phase 3 clinical study of tapentadol immediate release (IR) tablets, a novel, investigational, centrally acting oral analgesic, showed that patients receiving 50 mg, 75 mg, or 100 mg of the medication experienced significant relief in acute pain after bunionectomy, a standard foot surgery associated with predictable levels of moderate to severe pain.

The overall difference in the intensity of pain experienced by patients recovering from bunionectomy was examined over the first 12, 24, 48 and 72 hours after initiating treatment with tapentadol. All tapentadol IR treatment groups showed a statistically significant improvement in pain over patients who received placebo, over all of these time periods (P<0.001).

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) presented these new data in a poster session at the 27th Annual Scientific Meeting of the American Pain Society (APS) in Tampa, Florida.

Treatment with 100 mg of tapentadol IR resulted in 79 percent of patients experiencing at least a 30 percent improvement in pain intensity at 48 hours. This is comparable to the 78 percent of patients who experienced the same percentage of improvement with 15 mg of oxycodone IR. Compared with placebo, the incidence of adverse events was higher for tapentadol IR and oxycodone IR treatment groups with a dose-
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development,L.L.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... For the pharmaceutical industry, marketplace success is tied to ... importance of the managed markets function - which is pharma,s ... payer formularies and provider networks play an increasingly large role ... time, managed markets leaders must continually identify the optimal resource ...
(Date:1/23/2015)... Jan. 23, 2015  The Partnership to Fight Chronic Disease (PFCD) released ... care leaders and a new study analyzing the impact of increased ... a nationwide coalition working to educate policy makers and the public ... Capitol was focused on how the Iowa ...
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. today ... Inc. for the compounding, packaging and distributing of its naltrexone ... the United States . KRS ... compounding naltrexone tablets in various strengths for individual patients in ...
Breaking Medicine Technology:As Payer Influence Rises, Pharmaceutical Companies work to Optimize the Managed Markets Function 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4
... NORCROSS, Ga., Feb. 24, 2012   Molnlycke Health Care US, LLC, ... announces it has acquired the assets of Brennen Medical (St. ... Care. In this transaction (terms not disclosed), ... Assets of Brennen Medical within the Burn and Wound Care ...
...  Mylan Inc. (Nasdaq: MYL ) today announced ... the company,s Mylan Pharmaceuticals subsidiary, has been elected to ... board of directors. GPhA is an association that represents ... election to this role further supports Mylan,s mission to ...
Cached Medicine Technology:Molnlycke Health Care Acquires the Burn and Wound Care Business From Brennen Medical 2Mylan Pharmaceuticals President Tony Mauro Elected Chairman of GPhA 2
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 IsoComforter, Inc. ... therapy machine with patented IsoTube design to treat specific body ... introduced the most progressive and easy to use patented cold ... post-operative and sports related orthopedic and muscle injuries. IsoComforter ...
(Date:1/22/2015)... 2015 Payday lending practices in four ... cause financial distress to the states that permit them, ... University’s Center on Race and Wealth. , While they ... payday loans at the same time substantially depress economic ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 As ... of overall health care gains momentum worldwide, Rev. Eric ... HealthCare Chaplaincy Network (HCCN), will be the keynote ... spiritual care in Israel’s public health system. , The conference, ...
(Date:1/22/2015)... released a new blog post presenting a list of vehicles that ... , Some types of vehicles cannot be covered under an ordinary ... to see if their vehicle qualifies for auto insurance coverage. ... cars that cannot be covered by a plan. Clients have little ...
Breaking Medicine News(10 mins):Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... and Discuss Emerging Advances in Basic Research ... Symposium, ABBOTT PARK, Ill., Nov. 1 The ... use to,communicate to one another, in order to maintain ... Based on a growing body of,scientific knowledge related to ...
... Capsugel will,unveil the successor to its unique Xcelodose ... vials at the American Association of,Pharmaceutical Scientists (AAPS) ... The new Xcelodose S system will feature ... Additional improvements include an integral High,Throughput Unit and ...
... a leading global clinical,research organization is delighted to announce that ... Trials Conference; which will be held,November 5th to 8th, 2007 ... sponsor "welcome coffee breaks" from 7:00 to,8:20 am on Nov. ... Chiltern will,also be present at exhibit booth 66. "We ...
... Confessions/ Testimonials for ... and LONDON, Nov. 1 Thomson,Scientific, part of ... TOC) and,leading provider of information solutions to the ... of its new campaign,"Confessions ... of a User." ...
... Oct. 31 All-State Properties, L.P.,announced today the ... Technology Co., Ltd. which contemplated a reverse,merger with ... terms of the Acquisition Agreement, Hubei Longdan is,obligated ... the transaction,as well as expenses relating to maintenance ...
... MIAMI, Oct. 31 Pensacola, FL-based Cogon Systems, ... (HIE) for South,Florida known as the South Florida ... participating providers who undergo a,short training session will ... search for,patient data from multiple healthcare organizations. ...
Cached Medicine News:Health News:Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition 2Health News:Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition 3Health News:Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition 4Health News:Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition 5Health News:New Generation Xcelodose(R)S Precision Drug Powder Micro-filling System Offers 50% Increased Throughput 2Health News:Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam 2Health News:Thomson Scientific Launches 'Confessions ... of a User' Campaign Asking 'Are You the New Face of Research?' 2Health News:South Florida HIE Phase II Completed and Phase III Awarded 2
... OTI-Scan 3D is the ... system available today. This ... and A-scan system operates ... desktop or laptop computer ...
... is a portable, digital A-scan system which ... of a high frequency, low noise probe ... immediately upon application of the probe along ... live A-scan display, storage of 5 different ...
... Echoscan US-800 Ultrasonic A-Scan offers ... compact, portable package. Besides,its compact ... highly accurate measurement and easy ... automatic freezing and manual gate.,NIDEK ...
... first very high frequency digital ultrasound eye ... provides microscopic resolution images and precision measurement ... of the human eye. Artemis is a ... In use, the patient leans forward placing ...
Medicine Products: